---
title: 'Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate
  the effect of implementation of the Truenat platform/MTB assays at primary health
  care clinics in Mozambique and Tanzania (TB-CAPT CORE)'
date: '2024-01-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38243223/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240120170620&v=2.18.0
source: heidelberg[Affiliation]
description: 'BACKGROUND: In 2020, the WHO-approved Molbio Truenat platform and MTB
  assays to detect Mycobacterium tuberculosis complex (MTB) and resistance to rifampicin
  directly on sputum specimens. This primary health care center-based trial in Mozambique
  and Tanzania investigates the effect of Truenat platform/MTB assays (intervention
  arm) combined with rapid communication of results compared to standard of care on
  TB diagnosis and treatment initiation for microbiologically confirmed TB at 7 days
  ...'
disable_comments: true
---
BACKGROUND: In 2020, the WHO-approved Molbio Truenat platform and MTB assays to detect Mycobacterium tuberculosis complex (MTB) and resistance to rifampicin directly on sputum specimens. This primary health care center-based trial in Mozambique and Tanzania investigates the effect of Truenat platform/MTB assays (intervention arm) combined with rapid communication of results compared to standard of care on TB diagnosis and treatment initiation for microbiologically confirmed TB at 7 days ...